Fundamental Analysis (FA)
Framework: DCF Benchmarked
Join Palmy To Bypass The Blur →
For ZM
Valuation Weak
14%
Profitability n.A.
Fin. Growth Weak
33%
Leverage & Liquidity Weak
33%
Per Share Metrics Positive
67%
Fin. Health n.A.
Fundamental Analysis (FA)
Benchmarked
1 Financial Health
Metric Q4 Q1 Δ in %
Current Ratio -3.16 4.36 4.50
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA 68.64 -4.93 -15.72
Naive Interpretation member
2 Per Share
Metric Q4 Q1 Δ in %
Book Value 2.52 26.88 26.22
Cash 5.08 23.92 22.77
Capex 1.10 -0.06 -0.06
Free Cash Flow 69.64 1.85 1.09
Revenue -1.38 3.70 3.75
Naive Interpretation member
3 Profitability
Metric Q4 Q1 Δ in %
Gross Margin -6.84 0.71 0.76
Operating Margin 64.64 0.24 0.15
ROA -30.19 0.02 0.03
ROE -30.05 0.03 0.04
ROIC 38.68 0.02 0.02
Naive Interpretation member
4 Valuation
The "Valuation Entry" for the Focus of ZM is permitted for members.
5 Growth
The "Growth Entry" for the Focus of ZM is permitted for members.
6 Leverage & Liquidity
The "Leverage & Liquidity Entry" for the Focus of ZM is permitted for members.